Discover the power of real-time signals plus AI
Every funding round, exec hire, M&A move, contract, and sentiment shift on Colossal — with verified, ICP-scored contact reveals (email + mobile) on demand.
Trusted by founders, sales teams, recruiters, and investors at firms like BlackRock, Oracle, Kleiner Perkins, and HubSpot.
Colossal Secures $60M Series A Funding To Advance Genetic Engineering And De-Extinction Technologies
Amount Raised
$60 Million
Round Type
series a
Description
Colossal Biosciences, a breakthrough biosciences and genetic engineering company, announced an oversubscribed $60M Series A financing led by Thomas Tull and At One Ventures with participation from Untamed Planet, Animoca Brands, Breyer Capital, Animal Capital, Arch Ventures co-founder Robert Nelsen, Paris Hilton, Bold Capital, First Light Capital Group, Boost VC, Jazz Ventures, Builders VC, Green Sands Equity, Draper Associates, Charles Hoskinson, among others, bringing total funding to $75M.
Funding Insights
Based on industry dataWatching Colossal? See every signal — funding, hires, M&A, contracts, sentiment.
See plans